Provider Notice issued 09/24/2024
To: | Enrolled Physicians; Physician Assistants; Advanced Practice Registered Nurses; and Pharmacies |
Date | September 24, 2024 |
Re: |
No Prior Authorization for Buprenorphine Prescriptions per Public Act 103-1040 |
The Department of Healthcare and Family Services (HFS) is providing this notice to announce that in accordance with Public Act 103-1040, Buprenorphine will no longer require a prior authorization to bypass edits for age or dosage.
This policy is effective immediately and applies to the fee-for-service (FFS) program and managed care organizations (MCOs).
Questions regarding this notice may be directed to a pharmacy consultant in the Bureau of Professional and Ancillary Services at 877-782-5565 for FFS claims, or the appropriate MCO.
Kelly Cunningham, Administrator
Division of Medical Programs